King Street, Helios Plan Bay Area Life Science Campus

King Street Properties and Helios Real Estate have received approval to build a 475K SF life science campus in Burlingame on the eastern coast of San Francisco’s peninsula.

The partners will build office and research buildings at 1669 and 1699 Old Bayshore Highway and 810 and 821 Malcolm Road, according to a report in the San Francisco Business Times.

Boston-based King Street bought the four parcels in February for $45.2M. Four office, industrial and restaurant buildings encompassing about 100K SF will be demolished to make way for the new life science campus.

King Street and San Francisco-based Helios plan a north campus featuring a seven-story, 193K SF building and a south campus with an eight-story, 282K SF building with a ground-floor café and meeting room.

A nine-story parking garage will be adjacent to the south campus building. Both buildings in the campus, designed by Chicago-based Perkins&Will, will feature rooftop terraces and ground-floor plazas.

The partners have agreed to contribute $100K to the City of Burlingame for Bay Trail improvements, including a crosswalk that connects public plazas at the life science campus to the Bay Trail.

Last month, King Street broke ground on Allston Labworks, a $915M life sciences development with retail and residential space on Western Avenue in Boston. The mixed-use project is rising at the 4.3-acre former site of Stadium Auto Body, at the intersection of Western Avenue and Everett Street.

King Street is planning three buildings encompassing 534K SF of lab space, 35 residential units, 20K SF of retail and a 12K plaza. This summer, King Street and its partners secured a $585M construction loan for Allston Labworks, which is scheduled to be completed by the end of 2021.

King Street also has started construction on Pathway Triangle, a 1M SF purpose-built biotech campus on 75 acres along McCrimmon Parkway in Morrisville, North Carolina.

Pathway Triangle is planned as a center for the life cycle of full pharmaceutical development. Phase one of the three-building project will be two GMP buildings encompassing 160K SF and 120F SF, respectively. A third building at the campus will total 140K SF.

In 2020, King Street created a real estate platform, called The Pathway, to give life science companies a “pathway to a cure” by creating customizable turnkey biomanufacturing space.

The Morrisville project will be King Street’s second purpose-built biomanufacturing campus; the first was Pathway Devens in Devens, MA.